530 related articles for article (PubMed ID: 33727051)
1. Development of multi-epitope peptide-based vaccines against SARS-CoV-2.
Lim HX; Lim J; Jazayeri SD; Poppema S; Poh CL
Biomed J; 2021 Mar; 44(1):18-30. PubMed ID: 33727051
[TBL] [Abstract][Full Text] [Related]
2. Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses.
Aparicio B; Casares N; Egea J; Ruiz M; Llopiz D; Maestro S; Olagüe C; González-Aseguinolaza G; Smerdou C; López-Díaz de Cerio A; Inogés S; Prósper F; Yuste JR; Carmona-Torre F; Reina G; Lasarte JJ; Sarobe P
Emerg Microbes Infect; 2021 Dec; 10(1):1931-1946. PubMed ID: 34538222
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 coronavirus vaccine T cell epitope prediction analysis based on distributions of HLA class I loci (HLA-A, -B, -C) across global populations.
Cun Y; Li C; Shi L; Sun M; Dai S; Sun L; Shi L; Yao Y
Hum Vaccin Immunother; 2021 Apr; 17(4):1097-1108. PubMed ID: 33175614
[TBL] [Abstract][Full Text] [Related]
4. Revelation of Potent Epitopes Present in Unannotated ORF Antigens of SARS-CoV-2 for Epitope-Based Polyvalent Vaccine Design Using Immunoinformatics Approach.
Uttamrao PP; Sathyaseelan C; Patro LPP; Rathinavelan T
Front Immunol; 2021; 12():692937. PubMed ID: 34497604
[TBL] [Abstract][Full Text] [Related]
5. Immunoinformatics prediction of overlapping CD8
Fatoba AJ; Maharaj L; Adeleke VT; Okpeku M; Adeniyi AA; Adeleke MA
Vaccine; 2021 Feb; 39(7):1111-1121. PubMed ID: 33478794
[TBL] [Abstract][Full Text] [Related]
6. Landscape and selection of vaccine epitopes in SARS-CoV-2.
Smith CC; Olsen KS; Gentry KM; Sambade M; Beck W; Garness J; Entwistle S; Willis C; Vensko S; Woods A; Fini M; Carpenter B; Routh E; Kodysh J; O'Donnell T; Haber C; Heiss K; Stadler V; Garrison E; Sandor AM; Ting JPY; Weiss J; Krajewski K; Grant OC; Woods RJ; Heise M; Vincent BG; Rubinsteyn A
Genome Med; 2021 Jun; 13(1):101. PubMed ID: 34127050
[TBL] [Abstract][Full Text] [Related]
7. 3CL hydrolase-based multiepitope peptide vaccine against SARS-CoV-2 using immunoinformatics.
Jakhar R; Kaushik S; Gakhar SK
J Med Virol; 2020 Oct; 92(10):2114-2123. PubMed ID: 32379348
[TBL] [Abstract][Full Text] [Related]
8. Multiepitope Subunit Vaccine Design against COVID-19 Based on the Spike Protein of SARS-CoV-2: An
Dar HA; Waheed Y; Najmi MH; Ismail S; Hetta HF; Ali A; Muhammad K
J Immunol Res; 2020; 2020():8893483. PubMed ID: 33274246
[TBL] [Abstract][Full Text] [Related]
9. Immunoinformatic design of a COVID-19 subunit vaccine using entire structural immunogenic epitopes of SARS-CoV-2.
Behmard E; Soleymani B; Najafi A; Barzegari E
Sci Rep; 2020 Nov; 10(1):20864. PubMed ID: 33257716
[TBL] [Abstract][Full Text] [Related]
10. Immunoinformatic Analysis of SARS-CoV-2 Nucleocapsid Protein and Identification of COVID-19 Vaccine Targets.
Oliveira SC; de Magalhães MTQ; Homan EJ
Front Immunol; 2020; 11():587615. PubMed ID: 33193414
[TBL] [Abstract][Full Text] [Related]
11. An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study.
Yang Z; Bogdan P; Nazarian S
Sci Rep; 2021 Feb; 11(1):3238. PubMed ID: 33547334
[TBL] [Abstract][Full Text] [Related]
12. Immuno-informatics approach for B-cell and T-cell epitope based peptide vaccine design against novel COVID-19 virus.
Singh J; Malik D; Raina A
Vaccine; 2021 Feb; 39(7):1087-1095. PubMed ID: 33478787
[TBL] [Abstract][Full Text] [Related]
13. A vaccine built from potential immunogenic pieces derived from the SARS-CoV-2 spike glycoprotein: A computational approximation.
Marchan J
J Immunol Methods; 2022 Mar; 502():113216. PubMed ID: 35007561
[TBL] [Abstract][Full Text] [Related]
14. Design of an epitope-based peptide vaccine against the SARS-CoV-2: a vaccine-informatics approach.
Alam A; Khan A; Imam N; Siddiqui MF; Waseem M; Malik MZ; Ishrat R
Brief Bioinform; 2021 Mar; 22(2):1309-1323. PubMed ID: 33285567
[TBL] [Abstract][Full Text] [Related]
15. Immuno-informatics design of a multimeric epitope peptide based vaccine targeting SARS-CoV-2 spike glycoprotein.
Chukwudozie OS; Gray CM; Fagbayi TA; Chukwuanukwu RC; Oyebanji VO; Bankole TT; Adewole RA; Daniel EM
PLoS One; 2021; 16(3):e0248061. PubMed ID: 33730022
[TBL] [Abstract][Full Text] [Related]
16. Scrutinizing the SARS-CoV-2 protein information for designing an effective vaccine encompassing both the T-cell and B-cell epitopes.
Jain N; Shankar U; Majee P; Kumar A
Infect Genet Evol; 2021 Jan; 87():104648. PubMed ID: 33264668
[TBL] [Abstract][Full Text] [Related]
17. A Highly Conserved Peptide Vaccine Candidate Activates Both Humoral and Cellular Immunity Against SARS-CoV-2 Variant Strains.
Gao F; Huang J; Li T; Hu C; Shen M; Mu S; Luo F; Song S; Hao Y; Wang W; Han X; Qian C; Wang Y; Wu R; Li L; Li S; Jin A
Front Immunol; 2021; 12():789905. PubMed ID: 34950151
[TBL] [Abstract][Full Text] [Related]
18. T and B cell Epitope analysis of SARS-CoV-2 S protein based on immunoinformatics and experimental research.
Chen Z; Ruan P; Wang L; Nie X; Ma X; Tan Y
J Cell Mol Med; 2021 Jan; 25(2):1274-1289. PubMed ID: 33325143
[TBL] [Abstract][Full Text] [Related]
19. A reverse vaccinology and immunoinformatics approach for designing a multiepitope vaccine against SARS-CoV-2.
Jahangirian E; Jamal GA; Nouroozi M; Mohammadpour A
Immunogenetics; 2021 Dec; 73(6):459-477. PubMed ID: 34542663
[TBL] [Abstract][Full Text] [Related]
20. Immunoinformatics mapping of potential epitopes in SARS-CoV-2 structural proteins.
Devi YD; Goswami HB; Konwar S; Doley C; Dolley A; Devi A; Chongtham C; Dowerah D; Biswa V; Jamir L; Kumar A; Satapathy SS; Ray SK; Deka RC; Doley R; Mandal M; Das S; Singh CS; Borah PP; Nath P; Namsa ND
PLoS One; 2021; 16(11):e0258645. PubMed ID: 34780495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
